SCHEMBL14747249

SCHEMBL14747249

Cc1ncc([C@@H]2CCCN2C)c2c1CCCN2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
CHRNA7 P36544 2/20 0.38
CHRNB2 P17787 2/20 0.38
CHRNB4 P30926 2/20 0.38
CHRNA3 P32297 2/20 0.38
CHRNA4 P43681 2/20 0.38
CHRNA2 Q15822 2/20 0.38
LMNA P02545 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HTR3E A5X5Y0 1/20 0.38
PSIP1 O75475 1/20 0.38
TRPA1 O75762 1/20 0.38
HTR3B O95264 1/20 0.38
CHRNA1 P02708 1/20 0.38
CHRNG P07510 1/20 0.38
MAPT P10636 1/20 0.38
CHRNB1 P11230 1/20 0.38
CYP2A6 P11509 1/20 0.38
PTGS1 P23219 1/20 0.38
CHRNA5 P30532 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14747251 0.90 ALDH1A1 (0.38) ALDH1A1CHRNA7CHRNB2CHRNB4CHRNA3
SCHEMBL13017564 0.84 CHRNB4 (0.39) ALDH1A1CHRNA7CHRNB2CHRNB4CHRNA3
SCHEMBL14747561 0.79 CHRNB4 (0.39) ALDH1A1CHRNA7CHRNB2CHRNB4CHRNA3
SCHEMBL14747250 0.78 CHRNB2 (0.39) ALDH1A1CHRNA7CHRNB2CHRNB4CHRNA3
SCHEMBL14747248 0.76 ALDH1A1 (0.37) ALDH1A1CHRNA7CHRNB2CHRNB4CHRNA3
SCHEMBL13017559 0.74 CHRNB4 (0.43) ALDH1A1CHRNA7CHRNB2CHRNB4CHRNA3
SCHEMBL14747247 0.73 CHRNB2 (0.42) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL14747256 0.72 CHRM2 (0.37) ALDH1A1CHRNA7LMNATDP1
SCHEMBL14747253 0.71 ALDH1A1 (0.41) ALDH1A1CHRNA7CHRNB2CHRNB4CHRNA3
SCHEMBL13017555 0.70 CHRNB4 (0.44) ALDH1A1CHRNA7CHRNB2CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130131015-A1 SYNTHESIS AND REGIOSELECTIVE SUBSTITUTION OF 6-HALO- AND 6-ALKOXY NICOTINE DERIVATIVES UNIV NORTH CAROLINA STATE (US) 2013-05-23 US disclosed
US-8389732-B2 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives NORTH CAROLINA STATE UNIVERSITY (US) 2013-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131015-A1 SYNTHESIS AND REGIOSELECTIVE SUBSTITUTION OF 6-HALO- AND 6-ALKOXY NICOTINE DERIVATIVES CHRNA6, CHRNA7, CHRNA4 ALDH1A1 1366/4885CHRNA7 2/4885CHRNB2 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.